小柴胡汤对食管癌化疗增敏及免疫耐受的逆转作用

李燕; 刘怀民; 彭亮; 张丽红; 付槟梵

doi:10.3969/j.issn.1671-038X.2018.07.07

小柴胡汤对食管癌化疗增敏及免疫耐受的逆转作用

- 1. 郑州大学附属肿瘤医院中西医结合科, 河南郑州 450000;
- 2. 阜外华中心血管病医院心血管内科, 河南郑州 450000
基金项目:
河南省科技厅重点科技攻关项目（No：152102310155）

详细信息

作者简介:
李燕,医学博士,主治医师,研究方向:中西医结合治疗肿瘤疾病

通讯作者: 刘怀民,E-mail:liyanmed@163.com

中图分类号: R735.1

Clinical observation of treatment and immune tolerance reversion in esophageal squamous carcinoma patients with XiaoChaiHu decoction combined chemotherapy

- 1. Department of Integrated Chinese and Western Medicine, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450000, China;
- 2. Department of Cardiovascular, Fuwai Central China Cardiovascular Hospital, Zhengzhou 450000, China

More Information

Corresponding author: LIU Huai-min, E-mail: liyanmed@163.com

摘要

摘要: [目的]观察小柴胡汤联合紫杉醇加顺铂（TP）方案对晚期食管癌患者的疗效以及对免疫功能的影响并探讨其相关机制。[方法]晚期食管癌患者150例，随机分为对照组（75例）和观察组（75例），对照组仅予TP方案静脉化疗，观察组在化疗基础上口服小柴胡汤，21 d为1周期，2周期后评估疗效及不良反应事件。采用流式细胞术检测患者化疗前后免疫功能评估免疫激活及免疫耐受状态。[结果]与对照组相比，观察组的有效率和控制率都有显著提高（P<0.05）。主要不良反应为中性粒细胞减少及消化道反应，观察组发生率明显减少（均P<0.05）。与化疗前相比，2组的免疫功能均有所恢复，观察组联合化疗后T细胞总数及亚群的逆转幅度更为明显，且差异有统计学意义（P<0.05）。[结论]小柴胡汤联合TP方案可提高化疗有效率、减少不良反应发生，其机制很可能是小柴胡汤通过逆转外周血中免疫耐受，激活免疫应答发挥的作用。
- 小柴胡汤 /
- 食管癌 /
- 化疗增敏 /
- 免疫耐受
Abstract: [Objective] To observe the effect of XiaoChaiHu Decoction combined TP(paclitaxel + cisplatin) chemotherapy regime in advanced esophageal squamous carcinoma patients, and investigate its mechanism of Immune function.[Methods] 150 advanced esophageal squamous carcinoma patients were randomly divided into two groups, the control group (75 cases) which were treated with TP chemotherapy; and treatment groups (75 cases) which were treated with XiaoChaiHu Decoction combined the same chemotherapy.Both are 3 weeks for a course.After 2 courses, effectiveness and adverse effects were evaluated.Immune function was detected by Flow cytometer to assess immune response and tolerance.[Results] Effective rate and improvement of treatment group were higher than control group(P<0.05).Adverse events of granulocytopenia and gastrointestinal reaction were fewer in treatment group(P<0.05 respectively).After treatment, immune function was improved in both groups.The increase of total T cell and subgroup in treatment group were more obvious(P<0.05).[Conclusion] The regime of XiaoChaiHu Decoction combined TP chemotherapy can improve efficacy, reduce adverse reaction that may be result from reversing immune tolerance and stimulating immune response.
- XiaoChaiHu Decoction /
- esophageal carcinoma /
- chemotherapy enhancement response /
- immune tolerance

HTML全文

参考文献(6)

[1]	Chen W, Zheng R, Baade PD, et al.Cancer Statistics in China, 2015[J].CA Cancer J Clin, 2016, 66(2):115-132.
[2]	苏婷凤, 陈俊强, 林宇, 等.中晚期食管鳞癌紫杉醇联合不同铂类药加IMRT的预后分析[J].中华放射肿瘤学杂志, 2017, 26(1):35-40.
[3]	廖娟, 周云峰.化疗对晚期食管癌患者细胞免疫及调节T细胞的影响[J].现代临床医学, 2014, 40(1):32-34.
[4]	杨茜雯, 张铭, 金长娟, 等.食道通结方辅助化疗对中晚期食管癌鳞癌患者生存期及免疫功能的影响[J].中医杂志, 2017, 58(21):1838-1841.
[5]	王子龙.小柴胡汤加减治疗各系统疾病的相关探讨[J].中医临床研究, 2016, 8(23) 147-148.
[6]	许馨月.应用小柴胡汤加减治疗恶性肿瘤发热的临床观察[J].吉林医学, 2013, 34(12):2276-2276.